SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-12-29 17:10
Tx date 2021-12-24
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
57 - Exercise of rights

+15,774 vol
61,116
Filed 2021-12-29 17:10
Tx date 2021-12-24
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-15,774 vol
37,726
Filed 2021-08-19 15:50
Tx date 2021-08-18
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,461
+1,588 vol
$2.18 each
45,342
Filed 2021-08-19 15:49
Tx date 2021-08-18
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$260.40
+120 vol
$2.17 each
43,754
Filed 2021-08-19 15:49
Tx date 2021-08-18
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,333
+2,000 vol
$2.17 each
43,634
Filed 2021-08-19 15:49
Tx date 2021-08-18
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,230
+2,000 vol
$2.12 each
41,634
Filed 2021-06-28 13:30
Tx date 2021-06-25
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,390
+2,600 vol
$5.92 each
39,634
Filed 2021-06-22 14:50
Tx date 2021-06-18
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,714
+2,494 vol
$5.90 each
37,034
Filed 2021-03-08 17:47
Tx date 2021-03-04
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,549
+1,500 vol
$5.70 each
34,540
Filed 2021-03-08 17:47
Tx date 2021-03-04
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,700
+1,500 vol
$5.80 each
33,040
Filed 2021-03-08 17:46
Tx date 2021-03-08
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,549
+1,500 vol
$5.70 each
Filed 2021-03-08 17:46
Tx date 2021-03-08
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,700
+1,500 vol
$5.80 each
Filed 2021-03-08 16:16
Tx date 2021-03-08
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,549
+1,500 vol
$5.70 each
34,540
Filed 2021-03-08 16:16
Tx date 2021-03-08
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,549
+1,500 vol
$5.70 each
Filed 2021-03-08 16:15
Tx date 2021-03-08
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,700
+1,500 vol
$5.80 each
Filed 2021-03-08 16:15
Tx date 2021-03-08
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,700
+1,500 vol
$5.80 each
33,040
Filed 2020-12-23 12:23
Tx date 2020-12-19
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
57 - Exercise of rights

+15,531 vol
31,540
Filed 2020-12-23 12:22
Tx date 2020-12-19
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-26,750 vol
53,500
Filed 2020-08-28 07:53
Tx date 2020-08-27
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$320.00
+100 vol
$3.20 each
16,009
Filed 2020-02-03 17:27
Tx date 2019-12-19
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
57 - Exercise of rights
$159.09
+15,909 vol
$0.01 each
15,909
Filed 2020-02-03 17:27
Tx date 2018-10-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-03 17:27
Tx date 2019-12-19
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
$-267.50
-26,750 vol
$0.01 each
80,250
Filed 2019-03-05
Tx date 2018-12-19
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+107,000 vol
Filed 2019-03-05
Tx date 2018-12-19
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+107,000 vol
107,000
Filed 2018-12-27
Tx date 2018-10-16
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-27
Tx date 2018-12-19
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+107,000 vol
107,000